Keyphrases
Repurposing
100%
Peptidomimetics
100%
Rifampicin
100%
Azithromycin
100%
Gram-negative Pathogens
100%
Antibiotics
57%
Erythromycin
14%
E. Coli ST131
14%
Clinically Relevant Concentrations
14%
EC50
14%
Micromolar Concentration
14%
Minor Effect
14%
Mammalian Cells
14%
Klebsiella Pneumoniae (K. pneumoniae)
14%
Escherichia Coli
14%
Pharmacological Properties
14%
Fractional Inhibitory Concentration Index
14%
Potentiation
14%
Clindamycin
14%
Multidrug-resistant Isolates
14%
Carbapenem-resistant Escherichia Coli
14%
Peptide Hybrids
14%
High Selectivity
14%
Pseudomonas Aeruginosa (P. aeruginosa)
14%
Antimicrobial Peptides
14%
Pharmacology, Toxicology and Pharmaceutical Science
Rifampicin
100%
Peptidomimetics
100%
Infectious Agent
100%
Azithromycin
100%
Repurposing
100%
Antibiotics
71%
Escherichia coli
28%
Klebsiella pneumoniae
14%
Erythromycin
14%
EC50
14%
Peptoid
14%
Polypeptide Antibiotic Agent
14%
Pseudomonas aeruginosa
14%
Clindamycin
14%
Clavulanic Acid
14%
Biochemistry, Genetics and Molecular Biology
Fractional Inhibitory Concentration Index
14%
Ticarcillin
14%